'Well done India!': Mansukh Mandaviya Hails Covid Vaccination Effort As Over 87% Of Adult Population Fully Jabbed
India’s Covid-19 vaccination coverage has exceeded 190.50 crore (1,90,50,86,706) as per provisional reports till 7 am on Tuesday, noted the health ministry
New Delhi: Lauding India’s effort, Union Health Minister Mansukh Mandaviya on Monday said over 87 per cent of the adult population in the country has been inoculated with both doses of Covid-19 vaccine. “With the mantra of 'Sabka Saath & Sabka Prayas', India achieves complete vaccination of over 87% of its adult population. Well done India! Keep following COVID appropriate behaviour even after getting vaccinated," tweeted Mandaviya.
देश की 87% वयस्क आबादी का पूर्ण टीकाकरण।
— Dr Mansukh Mandaviya (@mansukhmandviya) May 10, 2022
With the mantra of 'Sabka Saath & Sabka Prayas', India achieves complete vaccination of over 87% of its adult population.
Well done India! 🇮🇳
Keep following COVID appropriate behaviour even after getting vaccinated. pic.twitter.com/mopx3gAYjp
The cumulative vaccination coverage in the country has exceeded 190.50 crore, the Union health ministry informed on Tuesday, reported news agency ANI. “India's COVID-19 vaccination coverage has exceeded 190.50 crore (1,90,50,86,706) as per provisional reports till 7 am today. This has been achieved through 2,37,09,334 sessions," the ministry said.
As of now more than 3.06 crore (3,06,99,031) adolescents have been administered the first dose of the vaccine, the health ministry added. The Covid-19 vaccination coverage for the age group 12-14 years began on March 16.
In a positive outlook, the daily Covid-19 cases also dipped in the country on Tuesday. Going by the health ministry data, 2,288 new Covid infections were reported across the country in the last 24 hours. With this, active Covid cases stands at 19,637, constituting 0.05 per cent of India's total positive cases.
In April, the health minister had said that the ministry of health will wait for recommendation from the Covid working group of NTAGI to begin the vaccination of kids aged 5 to 12. The Drugs Controller General of India (DCGI) recently approved emergency use authorisation to Bharat Biotech's Covaxin for children between the age group of 6-12 amid rise in the Covid-19 cases in schools.
Top Headlines
